# Babesiosis-Induced Hemophagocytic Lymphohistiocytosis Following Spontaneous Splenic Rupture in a Florida Resident: A Case Report

**Authors:** Abeer Jacob, Samir A Nacer, Nikesh Shah

PMC · DOI: 10.7759/cureus.83360 · Cureus · 2025-05-02

## TL;DR

A rare case of babesiosis-induced HLH with splenic rupture in a Florida resident highlights the importance of travel history and prompt diagnosis.

## Contribution

Reports a rare case of babesiosis-induced HLH in a non-endemic region with spontaneous splenic rupture.

## Key findings

- Babesiosis-induced HLH can present with spontaneous splenic rupture in non-endemic regions.
- Prompt diagnosis using PCR and blood smear is critical for effective treatment.
- Atovaquone and azithromycin effectively resolved HLH symptoms and lab abnormalities.

## Abstract

Babesiosis is a tick-borne protozoal infection caused by Babesia species, typically endemic to the northeastern United States. Cases in non-endemic regions, such as Florida, are exceptionally rare but can lead to severe complications if not promptly recognized. We report a case of hemophagocytic lymphohistiocytosis (HLH) secondary to babesiosis in a Florida resident who presented with spontaneous splenic rupture, a rare sequela of babesiosis. This patient, originally from New York, had a recent travel history to Maine, emphasizing the critical importance of a thorough epidemiological history in non-endemic areas. Diagnostic challenges were compounded by overlapping clinical features of HLH and sepsis. Key laboratory findings included anemia, thrombocytopenia, hyperferritinemia, and elevated inflammatory markers, with confirmatory diagnosis of babesiosis made via polymerase chain reaction (PCR) and peripheral blood smear. The patient responded well to atovaquone and azithromycin, with complete resolution of HLH symptoms and laboratory abnormalities. This case highlights the necessity for clinical vigilance, the integration of travel history into diagnostic evaluations, and the potential for fatal outcomes if babesiosis-induced HLH is not promptly diagnosed and treated. Increased awareness and training for clinicians in non-endemic regions, as well as public health measures, are essential to improving outcomes.

## Linked entities

- **Chemicals:** atovaquone (PubChem CID 74989), azithromycin (PubChem CID 447043)
- **Diseases:** babesiosis (MONDO:0005661), hemophagocytic lymphohistiocytosis (MONDO:0015540)

## Full-text entities

- **Diseases:** Splenic Rupture (MESH:D013161), hyperferritinemia (MESH:D000085583), protozoal infection (MESH:D020808), Babesiosis (MESH:D001404), anemia (MESH:D000740), tick (MESH:D013985), HLH (MESH:D051359), thrombocytopenia (MESH:D013921), sepsis (MESH:D018805), inflammatory (MESH:D007249)
- **Chemicals:** atovaquone (MESH:D053626), azithromycin (MESH:D017963)
- **Species:** Homo sapiens (human, species) [taxon 9606], Babesia (genus) [taxon 5864]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12127017/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12127017/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12127017/full.md

---
Source: https://tomesphere.com/paper/PMC12127017